EANM’09 – CME Session III
Drug Development / Radiopharmacy
October 11, 2009, 14:30 – 16:00
State of the Art of Radiopharmaceutical Production
Moderator: C. Halldin (Stockholm)
Co-Moderator: P. Elsinga (Groningen)
|R. Haubner (Innsbruck):
PET and SPECT Labelling of Peptides
|P. Elsinga (Groningen):
Application of Microfluidics in PET
|R. Schibli (Zurich):
Click Chemistry for PET and SPECT
- To know the scope, possibilities and limitations of PET and SPECT-labelling of peptides and the consequent for in vivo properties.
- To have an overview of advantages of microfluidics for PET-radiolabelling and its possible impact on future synthesis modules.
- To understand the advantages and challenges of click chemistry for the preparation of PET and SPECT radiopharmaceuticals.
Radiopharmaceutical chemistry is still rapidly developing. There is a need to develop more and better imaging tracers for existing and all the new targets that have recently been explored in the human body. Efforts are directed to more simple and efficient labelling procedures and technologies. The main aim of these efforts is a further dissemination of new radiolabelling methods to increase the number of tools (radiopharmaceuticals) for all these new targets where there is a need for new diagnostics in Nuclear Medicine and for imaging biomarkers in Drug Development.
This session will highlight and give an update of three areas that have attracted lot of attention in recent years and that have large potential for further development of new tracers using radiopharmaceutical chemistry.
Microfluidics, Click Chemistry, Peptides, PET, SPECT, Radiotracers, Carbon-11, Fluorine-18, Technetium-99m